Association between Serum Soluble Urokinase-Type Plasminogen Activator Receptor Level and Arterial Stiffness in Chronic Hemodialysis Patients

Association between Serum Soluble Urokinase-Type Plasminogen Activator Receptor Level and Arterial Stiffness in Chronic Hemodialysis Patients

Cardiovascular diseases (CVDs) remain a significant cause of death in hemodialysis (HD) patients. To explore their associations, we examine the role of soluble urokinase-type plasminogen activator receptor (suPAR) in arterial stiffness in chronic HD patients. From June to August 2020, we recruited 1...

Full description

Bibliographic Details
Main Authors: Wei-Chen Lin, Tsung-Jui Wu, Chih-Hsien Wang, Yi-Jen Hsieh, Bang-Gee Hsu
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:Journal of Personalized Medicine
Subjects:
carotid–femoral pulse-wave velocity
soluble urokinase-type plasminogen activator receptor
hemodialysis
arterial stiffness
Online Access:https://www.mdpi.com/2075-4426/13/3/470

Internet

https://www.mdpi.com/2075-4426/13/3/470

Similar Items